By the time you're done with this area you should accept a acceptable abstraction of the science abaft abscess and feel assured in how you would like to proceed.

Sunday, June 1, 2008

ERBITUX(R) (Cetuximab) Data Demonstrate Improved Overall Survival in First-Line Treatment of Advanced Non-Small Cell ... (Finanzen.net)

ImClone Systems Incorporated (NASDAQ: IMCL) and Bristol-Myers Squibb Company (NYSE: BMY) today announced results that show the addition of ERBITUX® (cetuximab) to platinum-based chemotherapy significantly increased overall ...

Post by Desouth at 6:52:00 AM

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)